Clinical Trial To Evaluate ANT-1207 In Participants With Primary Axillary Hyperhidrosis

Clinical Trial to Evaluate ANT-1207 in the Treatment of Primary Axillary Hyperhidrosis in Adults

The purpose of this study is to establish the therapeutic range of ANT-1207 in the treatment of primary axillary hyperhidrosis.

Inclusion Criteria:

• ages 18 - 70 years of age
• diagnosis of primary axillary hyperhidrosis
• HDSS score of ≥3
• threshold sweat production/axilla in 5 minutes as measured gravimetrically
• willingness to shave underarms prior to each study visit

Exclusion Criteria:

• botulinum toxin treatment in the prior 6 months
• signs of infection in the axilla
• skin affliction in the axilla requiring medical treatment
• oral anticholinergic treatment
• use of antiperspirants, deodorants, powders, or lotions
• use of axillary depilatories or axillary epilation
• history of surgery or other interventions for axillary hyperhidrosis
• female subjects who are pregnant or are nursing a child